The global wearable patch market size was valued at $7.7 billion in 2019 and is expected to expand at a CAGR of 6% from 2021 to 2027. Wearable patches are known as electronic skins or smart patches. They are used to monitor disease, diagnosis, and drug delivery, and to maintain the health of elderly patients suffering from chronic conditions like diabetes. The market is expected to witness profitable growth owing to increased R&D investment for the development of wearable patches. Wearable patches, such as transdermal patches and scopolamine patches, are attached directly to infected body parts for disease monitoring. For example, nicotine patches are used in nicotine replacement therapy (NRT) to release nicotine into the body and prevent smoking.
A full report of Wearable Patch Market available at https://www.orionmarketreports.com/wearable-patch-market/55760/
Wearable Patch Market: Segmentation
By Product
• Temperature Patch
• Blood Glucose Patch
• Blood Pressure Patch
• Heart Rate Patch & ECG Patch
• Skin Care Patch
• Others
By End Use
• Healthcare
• Fitness & Sports
Key Players
• AliveCor, Inc
• VivaLNK, Inc
• Cardiac Insight Inc
• VitalConnect
• LifeSignals, Inc
• L’Oreal Group
• Dexcom, Inc
• GENTAG, Inc
• Abbott Laboratories
• Koninklijke Philips N.V.
• Sensium Healthcare Ltd
• Leaf Healthcare, Inc
• Qualcomm Technologies, Inc
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
